✦ LIBER ✦

Exploiting the defensive sugars of HIV-1 for drug and vaccine design

✍ Scribed by Scanlan, Christopher N.; Offer, John; Zitzmann, Nicole; Dwek, Raymond A.

Book ID: 109896677
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 656 KB
Volume: 446
Category: Article
ISSN: 0028-0836
DOI: 10.1038/nature05818

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limitations to the structure-based desig

Limitations to the structure-based design of HIV-1 vaccine immunogens

✍ Marc H. V. Van Regenmortel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

## Abstract In spite of 25 years of intensive research, no effective human immunodeficiency virus type 1 (HIV‐1) vaccine has yet been developed. One reason for this is that investigators have concentrated mainly on the structural analysis of HIV‐1 antigens because they assumed that it should be pos

Design and construction of an experiment

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

✍ Hanke, Tomas; McMichael, Andrew J. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

A Possible Improvement for Structure-Bas

A Possible Improvement for Structure-Based Drug Design Illustrated by the Discovery of a Tat HIV-1 Inhibitor.

✍ Jacques Lebreton; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 165 KB 👁 2 views

A possible improvement for structure-bas

A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor

✍ Mickaël Montembault; Giang Vo-Thanh; Abdallah Deyine; Valérie Fargeas; Monique V 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Restrained molecular dynamics simulation

Restrained molecular dynamics simulations of HIV-1 protease: The first step in validating a new target for drug design

✍ Alexander L. Perryman; Jung-Hsin Lin; J. Andrew McCammon 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 804 KB

## Abstract To test the anticorrelated relationship that was recently displayed in conventional molecular dynamics (MD) simulations, several different restrained MD simulations on a wild type and on the V82F/I84V drug‐resistant mutant of HIV‐1 protease were performed. This anticorrelated relationsh

ChemInform Abstract: Darunavir (I), a Co

ChemInform Abstract: Darunavir (I), a Conceptually New HIV-1 Protease Inhibitor for the Treatment of Drug-Resistant HIV.

✍ Arun K. Ghosh; Zachary L. Dawson; Hiroaki Mitsuya 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 18 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v